Prediction the clinical EPR effect of nanoparticles in patient-derived xenograft models
Sangmin Jeon(Korea Institute of Science and Technology), Song Cheol Kim(Ulsan College), Suhwan Chang(Ulsan College), Man Kyu Shim(Korea Institute of Science and Technology), Eunji Jeong(Ulsan College), Eun‐Young Koh(Ulsan College), Ji Young Yhee(Green Cross (South Korea)), Hyeyoun Chang(Korea Institute of Science and Technology), Hong Yeol Yoon(Korea Institute of Science and Technology), Eunsung Jun(Asan Medical Center), Jong Won Lee(Korea University), Kwangmeyung Kim(Ewha Womans University), Yeounhee Kim(Ulsan College)
Cited by 57
Related Papers
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
|Proceedings of the National Academy of Sciences|2017|577
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
|Gastroenterology|2015|472
Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery
|Biomaterials|2013|352
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
|JNCI Journal of the National Cancer Institute|2019|299
A 3D-printed local drug delivery patch for pancreatic cancer growth suppression
|Journal of Controlled Release|2016|260